These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26319513)

  • 1. Identification of putative drug targets in Vancomycin-resistant Staphylococcus aureus (VRSA) using computer aided protein data analysis.
    Hasan MA; Khan MA; Sharmin T; Hasan Mazumder MH; Chowdhury AS
    Gene; 2016 Jan; 575(1):132-43. PubMed ID: 26319513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of potential drug targets by subtractive genome analyses of methicillin resistant Staphylococcus aureus.
    Uddin R; Saeed K
    Comput Biol Chem; 2014 Feb; 48():55-63. PubMed ID: 24361957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative genomics of vancomycin-resistant Staphylococcus aureus strains and their positions within the clade most commonly associated with Methicillin-resistant S. aureus hospital-acquired infection in the United States.
    Kos VN; Desjardins CA; Griggs A; Cerqueira G; Van Tonder A; Holden MT; Godfrey P; Palmer KL; Bodi K; Mongodin EF; Wortman J; Feldgarden M; Lawley T; Gill SR; Haas BJ; Birren B; Gilmore MS
    mBio; 2012; 3(3):. PubMed ID: 22617140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of potential drug targets by subtractive genome analysis of Bacillus anthracis A0248: An in silico approach.
    Rahman A; Noore S; Hasan A; Ullah R; Rahman H; Hossain A; Ali Y; Islam S
    Comput Biol Chem; 2014 Oct; 52():66-72. PubMed ID: 25254941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin-resistant Staphylococcus aureus--Pennsylvania, 2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Oct; 51(40):902. PubMed ID: 12418544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance.
    Hiramatsu K
    Lancet Infect Dis; 2001 Oct; 1(3):147-55. PubMed ID: 11871491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic pathway analysis approach: identification of novel therapeutic target against methicillin resistant Staphylococcus aureus.
    Uddin R; Saeed K; Khan W; Azam SS; Wadood A
    Gene; 2015 Feb; 556(2):213-26. PubMed ID: 25436466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
    Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
    J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.
    Appelbaum PC
    Clin Microbiol Infect; 2006 Mar; 12 Suppl 1():16-23. PubMed ID: 16445720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic organization of a vancomycin-resistant Staphylococcus aureus.
    Mirani ZA; Jamil N
    J Coll Physicians Surg Pak; 2013 Feb; 23(2):107-11. PubMed ID: 23374512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
    Weigel LM; Donlan RM; Shin DH; Jensen B; Clark NC; McDougal LK; Zhu W; Musser KA; Thompson J; Kohlerschmidt D; Dumas N; Limberger RJ; Patel JB
    Antimicrob Agents Chemother; 2007 Jan; 51(1):231-8. PubMed ID: 17074796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of a subtractive genomics approach for in silico identification and characterization of novel drug targets in Mycobacterium tuberculosis F11.
    Hosen MI; Tanmoy AM; Mahbuba DA; Salma U; Nazim M; Islam MT; Akhteruzzaman S
    Interdiscip Sci; 2014 Mar; 6(1):48-56. PubMed ID: 24464704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of oritavancin against community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA), vancomycin-intermediate S. aureus (VISA), vancomycin-resistant S. aureus (VRSA) and daptomycin-non-susceptible S. aureus (DNSSA).
    Saravolatz LD; Pawlak J; Johnson LB
    Int J Antimicrob Agents; 2010 Jul; 36(1):69-72. PubMed ID: 20413274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006.
    Sievert DM; Rudrik JT; Patel JB; McDonald LC; Wilkins MJ; Hageman JC
    Clin Infect Dis; 2008 Mar; 46(5):668-74. PubMed ID: 18257700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin.
    Hiramatsu K; Aritaka N; Hanaki H; Kawasaki S; Hosoda Y; Hori S; Fukuchi Y; Kobayashi I
    Lancet; 1997 Dec; 350(9092):1670-3. PubMed ID: 9400512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRSA--the tip of the iceberg.
    Appelbaum PC
    Clin Microbiol Infect; 2006 Apr; 12 Suppl 2():3-10. PubMed ID: 16524422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic analysis of vancomycin-resistant Staphylococcus aureus VRS3b and its comparison with other VRSA isolates.
    Panthee S; Hamamoto H; Paudel A; Sekimizu K
    Drug Discov Ther; 2017 May; 11(2):78-83. PubMed ID: 28458299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary analysis of the genetic basis for vancomycin resistance in Staphylococcus aureus strain Mu50.
    Avison MB; Bennett PM; Howe RA; Walsh TR
    J Antimicrob Chemother; 2002 Feb; 49(2):255-60. PubMed ID: 11815565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of high-level vancomycin-resistant Staphylococcus aureus in the Imam Khomeini Hospital in Tehran.
    Aligholi M; Emaneini M; Jabalameli F; Shahsavan S; Dabiri H; Sedaght H
    Med Princ Pract; 2008; 17(5):432-4. PubMed ID: 18685289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction of Novel Drug Targets against
    Beig M; Ebrahimi T; Goodarzi NN; Fereshteh S; Habibi M; Badmasti F
    Curr Pharm Des; 2023; 29(14):1135-1147. PubMed ID: 37132149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.